News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,604 Results
Type
Article (2401)
Company Profile (45)
Press Release (35158)
Section
Business (14106)
Career Advice (76)
Deals (2073)
Drug Delivery (8)
Drug Development (4082)
Employer Resources (10)
FDA (427)
Job Trends (759)
News (20105)
Policy (1050)
Tag
Academia (143)
Alliances (3459)
Alzheimer's disease (43)
Antibody-drug conjugate (ADC) (12)
Approvals (429)
Bankruptcy (11)
Best Places to Work (472)
Biosimilars (9)
Biotechnology (34)
Breast cancer (14)
Cancer (95)
Career advice (64)
CAR-T (9)
Cell therapy (30)
Clinical research (3116)
Collaboration (67)
Compensation (30)
COVID-19 (180)
C-suite (20)
Data (69)
Diagnostics (459)
Earnings (4141)
Employer resources (8)
Events (5896)
Executive appointments (64)
FDA (461)
Funding (61)
Gene editing (10)
Gene therapy (8)
GLP-1 (58)
Government (146)
Healthcare (701)
Infectious disease (183)
Inflammatory bowel disease (10)
Intellectual property (8)
IPO (980)
Job creations (289)
Job search strategy (62)
Layoffs (35)
Legal (210)
Lung cancer (15)
Manufacturing (16)
Medical device (305)
Medtech (305)
Mergers & acquisitions (1138)
Metabolic disorders (24)
Neuroscience (77)
NextGen: Class of 2025 (353)
Non-profit (155)
Northern California (260)
Obesity (11)
Opinion (13)
Patents (12)
People (5575)
Phase I (1341)
Phase II (1569)
Phase III (831)
Pipeline (41)
Postmarket research (30)
Preclinical (580)
Radiopharmaceuticals (12)
Rare diseases (13)
Real estate (419)
Regulatory (784)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (16)
Southern California (254)
Startups (487)
United States (1246)
Vaccines (22)
Weight loss (8)
Date
Today (8)
Last 7 days (27)
Last 30 days (151)
Last 365 days (2593)
2025 (135)
2024 (2619)
2023 (2859)
2022 (3754)
2021 (4050)
2020 (3473)
2019 (2064)
2018 (1556)
2017 (1797)
2016 (1626)
2015 (1834)
2014 (1369)
2013 (1189)
2012 (1396)
2011 (1333)
2010 (1181)
Location
Africa (42)
Arizona (13)
Asia (1842)
Australia (294)
California (592)
Canada (110)
China (30)
Colorado (13)
Connecticut (9)
Europe (3783)
Florida (34)
Illinois (13)
Indiana (23)
Kansas (12)
Maryland (21)
Massachusetts (208)
Minnesota (14)
New Jersey (37)
New York (36)
North Carolina (78)
Northern California (260)
Ohio (22)
Pennsylvania (27)
South America (40)
Southern California (254)
Texas (48)
Washington State (33)
37,604 Results for "kaleido biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Deals
Kaleido Biosciences Culls Staff, Prepares to Cease Operations
Shares of Kaleido Biosciences are plunging after the company announced its intentions to cease all company operations, lay off its remaining staff and delist from the Nasdaq Exchange.
April 8, 2022
·
2 min read
·
Alex Keown
Business
Kaleido Biosciences Reports Third Quarter 2021 Financial Results
Kaleido Biosciences, Inc. today reported financial results for the third quarter ended September 30, 2021.
November 1, 2021
·
7 min read
Business
Kaleido Biosciences Reports Second Quarter 2021 Financial Results
Kaleido Biosciences, Inc. today reported financial results for the second quarter ended June 30, 2021.
August 11, 2021
·
7 min read
Business
Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer
Kaleido Biosciences, Inc. today announced the appointment of Alison Long, M.B.B.Ch., Ph.D., to its leadership team as Chief Medical Officer, effective December 15, 2021.
November 10, 2021
·
5 min read
Genetown
Kaleido Biosciences to Participate in the Jefferies Virtual Next Generation IBD Therapeutics Summit
Kaleido Biosciences, Inc. today announced that CEO Dan Menichella will present a company overview at the Jefferies Virtual Next Generation IBD Therapeutics Summit at 1:45PM ET on Tuesday, October 19.
October 12, 2021
·
1 min read
Genetown
Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference
Kaleido Biosciences, Inc. today announced that CEO Dan Menichella will deliver a corporate presentation at the JMP Securities Life Sciences Conference at 4PM ET on Thursday, June 17.
June 10, 2021
·
1 min read
Business
Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions
Kaleido Biosciences, Inc. today announced the extension and expansion of its research collaboration with Janssen Biotech, Inc. (“Janssen”).
December 6, 2021
·
4 min read
Press Releases
Anixa Biosciences CEO Provides Letter to Shareholders
January 21, 2025
·
6 min read
Genetown
Kaleido Biosciences to Participate in the 41st Annual Canaccord Genuity Growth Conference
Kaleido Biosciences, Inc. today announced that CFO William Duke will participate in a fireside chat at the Canaccord Genuity Growth Conference at 2:30PM ET on Thursday, August 12.
August 6, 2021
·
1 min read
1 of 3,761
Next
